Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

862.86 +18.36 (+2.17%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Eli Lilly Delivers Strong Q3 Performance, Raises Earnings Outlook
Eli Lilly’s Q3 2025 revenue jumped 54% to $17.6 billion with adjusted EPS of $7.02, prompting the company to lift its full-year guidance. 
Via Talk Markets
These S&P500 stocks are moving in today's pre-market session
Get insights into the top gainers and losers in the S&P500 index of Thursday's pre-market session. 
Via Chartmill
Eli Lilly & Co (NYSE:LLY) Q3 2025 Earnings Beat Estimates, Fueling Pre-Market Rally
Eli Lilly's Q3 2025 results crushed estimates, driven by high demand for Mounjaro and Zepbound. The company raised its full-year outlook, sparking a stock rally. 
Via Chartmill
Topics Earnings
Eli Lilly Blows Past Expectations On The Back Of Mounjaro, Zepbound
Shares jumped early Thursday after the drugmaker easily topped third-quarter forecasts. 
Via Investor's Business Daily
Earnings Scheduled For October 30, 2025
 
Via Benzinga
Earnings Outlook For Eli Lilly
 
Via Benzinga
Eli Lilly (NYSE:LLY) Delivers Strong Q3 Numbers, Stock Soars
Global pharmaceutical company Eli Lilly (NYSE:LLY) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 53.9% year on year to $17.6 billion. The company’s full-year revenue... 
Via StockStory
Understanding Market Records: Is This Sustainable Growth?
The global stock market is currently navigating an unprecedented era of record-breaking growth in late October 2025, a phenomenon largely orchestrated by the remarkable performance and pervasive... 
Via TokenRing AI
Topics Artificial Intelligence Economy Fraud
Nvidia Shatters Records: AI Powerhouse Hits $5 Trillion Market Cap, Reshaping Global Economy
In a historic moment for the technology and financial worlds, Nvidia Corporation (NASDAQ: NVDA) officially achieved an unprecedented $5 trillion market capitalization on Wednesday, October 29, 2025.... 
Via TokenRing AI
Topics Artificial Intelligence Economy Emissions
Eli Lilly Advances AI And Access: Supercomputer With NVIDIA, Zepbound Via Walmart
Eli Lilly partners with NVIDIA to build a powerful AI supercomputer and teams up with Walmart to expand affordable Zepbound access nationwide. 
Via Benzinga
Topics Artificial Intelligence
Nvidia Shatters Records with $5 Trillion Market Cap, Cementing AI Revolution Leadership
Santa Clara, CA – October 29, 2025 – In a historic moment for the technology sector, Nvidia (NASDAQ: NVDA) has officially achieved an unprecedented $5 trillion market capitalization, becoming the first... 
Via MarketMinute
Topics Artificial Intelligence Economy
Nvidia's 2 Surprises; NVDA Soars On Trump-Fueled Hopes of China Blackwell Sales; Fed In Focus
Two Nvidia Shockers Please click here for an enlarged chart of NVIDIA Corp (NASDAQ:NVDA). 
Via Benzinga
Topics Economy
Nvidia's AI Reign: Fueling Market Gains and Forging a New Industrial Revolution
Nvidia (NASDAQ: NVDA) stands as the undisputed titan of the artificial intelligence (AI) era, its stock performance a primary catalyst for the recent, unprecedented surge in global financial markets.... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
Via Investor Brand Network
Nanomedicine Innovations Transforming Oncology Drug Delivery and Bioavailability
EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOVA),(NYSE:MRK),(NYSE:LLY),(NYSE:JNJ) EQNX::TICKER_END 
Via FinancialNewsMedia
Eli Lilly Partners With Walmart To Expand Access To Popular Weight-loss Drug
Zepbound vials will be offered for pick-up at Walmart pharmacies nationwide by mid-November. 
Via Stocktwits
1 Incredible Reason to Buy Novo Nordisk Stock (NVO) in November -- or Sooner
It offers compelling weight-loss drugs -- and a compelling stock price, too. 
Via The Motley Fool
Could This Anti-Obesity Drug Biotech Be Poised to Soar in 2026?
This stock has caught fire after some recent events, but how long will that last? 
Via The Motley Fool
Eli Lilly (LLY) To Report Earnings Tomorrow: Here Is What To Expect
Global pharmaceutical company Eli Lilly (NYSE:LLY) will be announcing earnings results this Thursday before market open. Here’s what investors should know. 
Via StockStory
1 Undervalued Growth Stock Down 8% to Buy Before 2026
This momentary pullback represents an excellent opportunity to buy this high-flying stock. 
Via The Motley Fool
Topics World Trade
Eli Lilly Partners With Nvidia To Build Pharma’s Most Powerful AI Supercomputer
The Nvidia-powered system aims to cut drug development times and boost innovation. 
Via Talk Markets
Topics Artificial Intelligence
Why Nvidia (NVDA) Stock Is Up Today
Shares of leading designer of graphics chips Nvidia (NASDAQ:NVDA) jumped 5.2% in the afternoon session after CEO Jensen Huang laid out an overwhelmingly bullish case for the company's future at a... 
Via StockStory
Topics Artificial Intelligence Government World Trade
Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety
Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for pregnant women. 
Via Benzinga
Topics Lawsuit
Why NeoGenomics (NEO) Stock Is Trading Up Today
Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 1.1% in the morning session after it reported third-quarter 2025 results where revenue beat Wall Street's expectations. 
Via StockStory
Topics World Trade
If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These
These two have been neglected by Wall Street too much. 
Via The Motley Fool
Eli Lilly & Co (NYSE:LLY) Presents a High Growth Momentum and Technical Breakout Opportunity
Eli Lilly (LLY) is a top growth momentum stock with accelerating earnings, strong technical ratings, and a positive breakout setup for investors. 
Via Chartmill
Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers
As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Peering Into Eli Lilly and Co's Recent Short Interest
 
Via Benzinga
BDF-GESTION Trims Its Eli Lilly (LLY) Stake by 4,149 Shares
BDF-GESTION Trims Its Eli Lilly (LLY) Stake by 4,149 Shares 
Via The Motley Fool
What Is 1 of the Best Pharmaceutical Stocks to Buy Now?
This pharma giant is entering the rapidly expanding market for weight loss drugs. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.